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Treatment of Caenorhabditis elegans with apigenin, 5,7,40-trihydroxyﬂavone, induces larval growth
inhibition. To understand the molecular basis of apigenin-induced larval growth inhibition, the
effects of apigenin on DAF-16 activity were examined. DAF-16 was activated through nuclear trans-
location and the mRNA level of sod-3, one of the known DAF-16 target genes, was increased upon
apigenin treatment. DAF-16 activity was required for the growth inhibition, since the larval growth
retardation upon apigenin treatment was suppressed in daf-16 mutants. These results indicate that
apigenin acts as a stressor that activates DAF-16, which in turn inhibits larval growth.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction insulin-like signaling [7], which regulates numerous biologicalCaenorhabditis elegans is a good model organism to identify new
physiological roles of chemicals because it has well-deﬁned cell
lineages and developmental stages, and its complete genome se-
quence and vast genetic information are available.
Apigenin is a type of ﬂavone that is abundant in various fruits
and vegetables [1]. Most studies concerning the effects of apigenin
have been undertaken at the cellular level. The reports that
apigenin induces apoptosis in cancer cells and inhibits cell prolifer-
ation [2,3] have suggested apigenin as a promising cancer preven-
tion treatment. Apigenin also suppresses insulin-like growth factor
signaling, which regulates animal development [4]. Yet, the effects
of apigenin at the organismal level are not well understood. We
reported previously that apigenin treatment of C. elegans induces
larval growth inhibition [5]. Uptake and localization of apigenin
during C. elegans development was monitored using ﬂuorescent-
labeled apigenin [6]. Apigenin was shown to accumulate in the
pharynx prior to translocating to the amphid neurons, indicating
that apigenin in the medium was effectively incorporated into
the body and transported to a speciﬁc tissue, where it may affect
C. elegans development.
In this study, to understand the molecular basis of apigenin-
induced larval growth inhibition, the effects of apigenin on DAF-
16 activity were assessed. DAF-16, a C. elegans ortholog of the
FOXO transcription factor, is the downstream effector of DAF-2/chemical Societies. Published by Eactivities including larval growth [8]. Our results demonstrate that
DAF-16 is activated by apigenin treatment and that this activity is
required for apigenin-induced larval growth inhibition.2. Materials and methods
2.1. C. elegans strains and maintenance
C. elegans strains wild-type N2, DR26: daf-16(m26) I, CF1038:
daf-16(mu86) I, GR1352: daf-16(mgDf47) I; xrIs87, and CB1370:
daf-2(e1370) III were handled as described [9]. Strains were cul-
tured on nematode growth medium (NGM) agar plates containing
Escherichia coli OP50 with or without apigenin (see below), and
maintained at 20 C.
2.2. Apigenin treatment
Wormswere synchronized at the L1 larval stage by hatching em-
bryos without food, then grown on NGM agar plates containing
E. coli with or without different additives; 1% dimethyl sulfoxide
(DMSO) or 1 mM apigenin in 1% DMSO (P0 generation). DMSO
was used as a solvent for apigenin, thus DMSO-containing medium
was included in each experiment as a control. When the P0 worms
had grown to adults on respective medium, their embryos were
recovered and the procedure repeated to produce F1 and F2 gener-
ations. The rate of larval growthwasmeasured at the F2 generation.
Nuclear localization of GFP::DAF-16 and quantitative RT-PCR of
sod-3 were measured at the F1 generation.lsevier B.V. All rights reserved.
Fig. 1. Effects of apigenin on larval development. (A) The structure of apigenin,
5,7,40-trihydroxyﬂavone. (B) N2 larval growth rate on respective medium in the F2
generation. Percentages of F2 worms at each developmental stage are shown. L2–
L3, the L2–L3 larval-stage worms; L4, the L4 larval-stage worms; YA, young adult-
stage worms holding no embryo; Ad, adult-stage worms holding embryos; N,
number of worms examined. Each symbol indicates the value (condition) to which
another one was compared for P value calculation. (C) Nomarski images of typical
F2 worms grown on respective medium for 72 h. Scale bars, 100 lm.
3588 I. Kawasaki et al. / FEBS Letters 584 (2010) 3587–35912.3. Larval growth rate measurement
Growth of the worms for each generation was observed every
24 h for 3–4 days until the majority of the worms reached
adulthood. The growing worms were classiﬁed according to their
developmental stages, which were judged under a dissecting
microscope by their size, vulval morphology (open or closed),
and presence or absence of embryos in their uteri as follows: L2–
L3 larvae, larvae smaller than L4; L4 larvae, the largest larvae
where vulva is closed and embryos are not held; young adults,
worms where vulva is open but embryos are not yet held; adults,
worms where vulva is open and embryos are held in the uterus.
2.4. Observation of DAF-16 nuclear localization
GR1352 worms containing a gfp::daf-16 transgene were grown
on NGM plates with or without 1 mM apigenin for one generation
(P0), and their L1-synchronized progeny (F1) were grown on the
same medium until the L2–L3 stages. Worms were then observed
for nuclear localization of GFP::DAF-16 in the intestine and other
cells by ﬂuorescence microscopy.
2.5. Quantitative RT-PCR (qRT-PCR) of sod-3 mRNA
Worms were grown with or without apigenin for two (P0 and
F1) generations. Synchronized young-adult F1 worms were col-
lected, their total RNA and cDNA were prepared, and qRT-PCR
was performed as described [10]. Primers for sod-3 were 50-
TCGCACTGCTTCAAAGCTTGTTCAA-30 and 50-CCAAATCTGCATAGT-
CAGATGGGAGAT-30. Primers for act-1, which served as an internal
control, were 50-CCAGGAATTGCTGATCGTATGCAGAA-30 and 50-
TGGAGAGGGAAGCGAGGATAGA-30. The mRNA levels of sod-3 were
averaged from three independent experiments (each experiment
contained triplicate) and normalized with that of act-1 for
comparison.3. Results
3.1. Apigenin inhibits C. elegans larval growth
As previously described [6], treatment of wild-type N2 worms
with apigenin (Fig. 1A) caused inhibition of larval growth (Fig. 1B
and C). Larval growth of N2 worms grown on apigenin medium
for three (P0, F1, and F2) generations was monitored. Larval growth
on apigenin-containing medium was retarded compared to the
control worms grown for three generations on either NGM or
DMSO-containing medium (Fig. 1B). At 72 h in the F2 generation,
92.7% and 91.8% of the worms were already at the adult stage on
NGM and DMSO medium, respectively, while only 6.8% of the pop-
ulation were at the adult stage (P < 0.001, compared to the control
medium), and 11% were still at the L2–L3 stages on apigenin med-
ium (Fig. 1B). This apigenin-induced larval growth retardation was
more prominent in the F2 generation than in the F1 or P0 genera-
tion (data not shown). The molecular basis causing this intergener-
ational difference was not analyzed. Nomarski images of the
representative worms grown on respective medium are shown to
illustrate the larval growth retardation of N2 worms on apigenin
medium (Fig. 1C).
3.2. Apigenin induces DAF-16 nuclear localization
DAF-16 is activated by translocation from cytoplasm to nucleus
[11]. To test the possibility that DAF-16 activity was modulated
during apigenin-induced larval growth inhibition, worms contain-ing a gfp::daf-16 transgene were grown on apigenin medium and
the subcellular localization of the GFP::DAF-16 fusion protein
was observed. GFP::DAF-16 was translocated to the nuclei in the
intestine and other cells in 23.3% of the apigenin-treated worms
(Fig. 2A). On the other hand, nuclear localization of GFP::DAF-16
was not observed in any worms grown on NGM or DMSO medium
(Fig. 2A). These results indicate that treatment of worms with
apigenin induces DAF-16 nuclear localization.
3.3. DAF-16 is required for apigenin-induced larval growth inhibition
To clarify the involvement of daf-16 in apigenin-induced larval
growth inhibition, next we tested whether daf-16 loss-of-function
mutants could suppress the growth inhibition. Two daf-16mutants
were tested: daf-16(m26), which harbors a point mutation and is
considered to be a weak loss-of-function mutant [12], and
daf-16(mu86), which contains a deletion, and is a strong loss-of-
function mutant [13]. N2 and the daf-16 mutant worms were
grown for two (P0 and F1) generations, and their progeny (F2) were
synchronized at the L1 stage; then their larval growth rate was
measured (Figs. 2B and 3). As shown above, N2 worms grown for
two generations on apigenin medium contained a signiﬁcantly
smaller percentage of adults at 72 h (6.8%) compared to N2 worms
grown on NGM and DMSO media (92.7% and 91.8% adults at 72 h,
respectively; P < 0.001 for both media) (Figs. 1B and 3A). daf-
16(m26) worms grown on apigenin medium also contained a sig-
niﬁcantly smaller percentage of adults at 72 h (16.7%) compared
to daf-16(m26) worms grown on NGM and DMSO media (82.5%
Fig. 2. Apigenin induces DAF-16 nuclear localization. (A) GR1352 worms contain-
ing a gfp::daf-16 transgene were grown on respective medium until the L2–L3
stages in the F1 generation, then were observed for nuclear localization of
GFP::DAF-16 (see the magniﬁed insets). Percentages of F1 worms that displayed
DAF-16 nuclear localization on respective medium are shown in the accompanying
table. n, Number of worms examined. Scale bar, 100 lm. (B) Effects of apigenin
treatment on larval development of N2 and daf-16 mutant worms. Worms of each
genotype were grown on respective medium as indicated. Photographs of typical
worms in each population grown for 72 h in the F2 generation are shown.
Fig. 3. Apigenin-induced larval growth retardation is suppressed in daf-16mutants.
L1-synchronized F2 worms of each genotype were grown on respective medium
and were classiﬁed according to their developmental stages. The percentages of
each class at each time point are displayed as bar graphs. (A) N2 worms. (B) daf-
16(m26)worms. (C) daf-16(mu86)worms. P values were calculated using the values
of adult (Ad) percentage at 72 h in each population. Dotted lines indicate compared
values.
Fig. 4. sod-3 mRNA levels in N2 and daf-16 mutant worms grown on respective
medium. Total RNA was prepared from respective worm population in the F1
generation and the sod-3 mRNA level was quantiﬁed by qRT-PCR. Each symbol
indicates the value to which another value was compared for P value calculation.
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(Fig. 3B). On the other hand, daf-16(mu86) worms grown on apige-
nin medium contained 67.8% adults at 72 h, which was not signif-
icantly different from those in daf-16(mu86)worms grown on NGM
and DMSO media (83.3% and 78.3% adults at 72 h, respectively;
P = 0.18 and 0.27, respectively) (Fig. 3C). Thus, a strong loss-of-
function mutant daf-16(mu86), but not a weak loss-of-function
mutant daf-16(m26), suppressed the apigenin-induced larval
growth inhibition at statistically signiﬁcant levels. These results
indicate that certain level of DAF-16 activity is required for the
growth inhibition.
3.4. sod-3 mRNA level is increased upon apigenin treatment
Microarray and chromatin immunoprecipitation analyses have
demonstrated that sod-3 is one of the direct target genes that is
transcriptionally regulated by DAF-16 [8]. To assess whether
DAF-16 is actually activated upon apigenin treatment, the sod-3
mRNA level was quantiﬁed using qRT-PCR (Fig. 4). Total RNA was
prepared from N2 and the two daf-16 mutant worms for two (P0
and F1) generations for the analysis. The sod-3 mRNA level was in-
creased 1.77-fold in N2 worms grown on apigenin medium com-
pared to N2 worms grown on NGM medium (P < 0.05) (Fig. 4).
On the other hand, sod-3mRNA levels were not signiﬁcantly differ-
ent between daf-16 mutant worms grown on apigenin medium
and daf-16 mutant worms grown on NGM medium (Fig. 4). These
results indicate that sod-3 mRNA level and, thus, DAF-16 activity
was increased upon apigenin treatment.
Fig. 5. Weak dauer phenotype of daf-2(e1370) mutant is enhanced by apigenin treatment. L1-synchronized N2 and daf-2(e1370) worms were grown for two (P0 and F1)
generations on respective medium at 20 C and incidence of dauer larvae in each population was scored after 72 h. n, Number of worms examined in each population. Each
symbol indicates the value to which another value was compared for P value calculation. Photographs of typical worms in each population in the F1 generation are shown. A
N2 worm and a daf-2(e1370) worm in the apigenin medium are L4 larva and dauer larva, respectively. The other worms shown are adults.
Fig. 6. Proposed model for the action of apigenin on larval growth inhibition.
Arrows and T-bars represent positive and negative regulations, respectively.
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DAF-16 is the downstream effector of DAF-2/insulin-like signal-
ing in larval growth regulation [7]. To assess the possible interac-
tion between apigenin signal and the DAF-2/insulin-like
signaling, we tested whether a low penetrant dauer phenotype of
daf-2(e1370) mutant was affected by apigenin treatment (Fig. 5).
daf-2(e1370) is a temperature-sensitive dauer constitutive mutant,
which displays 100% penetrant dauer phenotype at 25 C and only
around 15% dauer formation at 20 C [14]. Although daf-2(e1370)
worms caused expected low levels of dauer formation at 20 C
when grown on NGM and DMSO media, they exhibited much high-
er levels of dauer formation when grown at 20 C on apigenin med-
ium (45.5% and 99.4% in the P0 and F1 generation, respectively;
P < 0.01) (Fig. 5). These results indicate that weak dauer phenotype
of daf-2(e1370) mutant was enhanced by apigenin treatment.
4. Discussion
Unlike the ﬂavone, 2-phenyl chromone [15], apigenin, 5,7,40-tri-
hydroxyﬂavone, did not induce embryonic lethality, but inhibited
larval growth in C. elegans (Fig. 1). In addition, among the 13
hydroxyﬂavones that have been examined, apigenin solely caused
larval growth inhibition [5]. These results suggest that hydroxyl-
ation of ﬂavones alter their physiological activities, and that the
position and number of hydroxylations are critical.
This study examined the possible involvement of DAF-16 in api-
genin-induced larval growth inhibition. DAF-16 regulates numer-
ous biological activities including larval growth, resistance to
oxidative stress, and longevity by activating target genes [8].
dFOXO, a Drosophila melanogaster ortholog, also regulates larval
growth as its overexpression causes larval growth inhibition [16].
DAF-16 is activated by translocation from cytoplasm to nucleus in
response to environmental stressors such as oxidative stress and
starvation. Here DAF-16 was translocated to the nucleus upon api-
genin treatment (Fig. 2A). It was also conﬁrmed that DAF-16was in-
deed activated upon apigenin treatment, since the mRNA level of
sod-3, one of the known DAF-16 target genes [8], was increased
upon apigenin treatment in a DAF-16-dependent fashion (Fig. 4).
Moreover, we demonstrated that DAF-16 activity is required for
the apigenin-induced larval growth inhibition, since the larval
growth retardation observed in N2worms upon apigenin treatment
was greatly suppressed in daf-16 mutants, and stronger suppres-
sion was observed in the stronger loss-of-function mutant (Fig. 3).
Collectively, these results indicate that apigenin acts as a stressor
that activates DAF-16, which in turn inhibits larval growth.Apigenin regulates insulin-like growth factor I receptor signal-
ing in mammals [4]. Here, the weak dauer phenotype of daf-
2(e1370)mutant was signiﬁcantly enhanced by apigenin treatment
(Fig. 5). This result suggests that apigenin signal inputs either in
parallel with the DAF-2/insulin-like signaling to promote DAF-16
activity or upstream of the DAF-2/insulin-like signaling to repress
DAF-2 activity (Fig. 6). How apigenin activates DAF-16 and how
it is related to the insulin-like signaling in C. elegans remain to be
examined further.
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